Total Liabilities: The total value of all possible claims against the corporation.
Collegium Pharmaceutical, Inc. (COLL) had Total Liabilities of $1.36B for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$205.45M |
|
$16.96M |
|
$77.07M |
|
$128.38M |
|
$144.69M |
|
$60.76M |
|
$-31.72M |
|
$29.04M |
|
$29.04M |
|
$16.96M |
|
$16.96M |
|
$16.96M |
|
$16.96M |
|
$60.76M |
|
$116.90M |
|
31.71M |
|
39.70M |
|
$0.52 |
|
$0.48 |
|
| Balance Sheet Financials | |
$691.41M |
|
$12.01M |
|
$965.42M |
|
$1.66B |
|
$440.03M |
|
$780.33M |
|
$915.13M |
|
|
Total Liabilities |
$1.36B |
$301.68M |
|
$-513.76M |
|
$301.68M |
|
31.71M |
|
| Cash Flow Statement Financials | |
$329.32M |
|
$-63.53M |
|
$-110.25M |
|
$96.61M |
|
$252.16M |
|
$155.55M |
|
$41.91M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.57 |
|
-- |
|
-- |
|
0.72 |
|
2.68 |
|
62.49% |
|
29.57% |
|
29.57% |
|
-- |
|
14.13% |
|
8.26% |
|
$327.58M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
1.88 |
|
0.97 |
|
92.58 |
|
5.62% |
|
-3.30% |
|
1.02% |
|
1.57% |
|
$9.51 |
|
$8.25 |
|
$8.29 |
|